FILOSTO, Massimiliano
 Distribuzione geografica
Continente #
NA - Nord America 6.483
EU - Europa 1.474
AS - Asia 760
SA - Sud America 6
AF - Africa 4
Continente sconosciuto - Info sul continente non disponibili 3
OC - Oceania 3
Totale 8.733
Nazione #
US - Stati Uniti d'America 6.467
HK - Hong Kong 477
UA - Ucraina 329
PL - Polonia 254
CN - Cina 217
IE - Irlanda 207
IT - Italia 163
GB - Regno Unito 152
DE - Germania 145
FI - Finlandia 132
SE - Svezia 44
FR - Francia 30
IN - India 30
CA - Canada 14
VN - Vietnam 13
SG - Singapore 10
RU - Federazione Russa 5
BE - Belgio 4
BR - Brasile 4
MU - Mauritius 4
TR - Turchia 4
TW - Taiwan 4
AT - Austria 3
AU - Australia 3
EU - Europa 3
NL - Olanda 3
AR - Argentina 1
IQ - Iraq 1
IR - Iran 1
IS - Islanda 1
JM - Giamaica 1
KR - Corea 1
KZ - Kazakistan 1
MS - Montserrat 1
PE - Perù 1
RO - Romania 1
SA - Arabia Saudita 1
SK - Slovacchia (Repubblica Slovacca) 1
Totale 8.733
Città #
Fairfield 1.311
Woodbridge 683
Ashburn 631
Seattle 583
Houston 528
Hong Kong 476
Wilmington 448
Cambridge 430
Princeton 402
Jacksonville 272
Warsaw 254
Ann Arbor 213
Dublin 207
New York 194
Chandler 150
Helsinki 111
San Diego 90
Des Moines 87
Brescia 60
London 51
Nanjing 45
Beijing 38
Shanghai 32
Dearborn 21
Pune 18
Norwalk 17
Nanchang 14
Shenyang 14
Dong Ket 12
Kilburn 11
Toronto 11
Lancaster 10
Changsha 9
Islington 9
Jinan 9
Chiswick 8
Hebei 8
Jiaxing 8
New Bedfont 8
Lappeenranta 7
Milan 7
Hanover 6
San Francisco 6
Tianjin 6
Hounslow 5
Kunming 5
Washington 5
Brussels 4
Chicago 4
Gardone Val Trompia 4
Gunzenhausen 4
Lanzhou 4
Strasbourg 4
São Paulo 4
Taipei 4
Acton 3
Boardman 3
Falkenstein 3
Genova 3
Kocaeli 3
Markham 3
Miami Beach 3
New Delhi 3
Prescot 3
Reno 3
Rome 3
Sydney 3
Augusta 2
Berlin 2
Bologna 2
Duncan 2
Esine 2
Fuzhou 2
Ghedi 2
Haikou 2
Hangzhou 2
Hefei 2
Jesolo 2
La Loggia 2
Lendinara 2
Mayfair 2
San Jose 2
Taizhou 2
Teramo 2
Tesero 2
Trento 2
Verona 2
Wandsworth 2
Zhengzhou 2
Atlanta 1
Borås 1
Bratislava 1
Brooklyn 1
Buffalo 1
Caselle Lurani 1
Cellatica 1
Changchun 1
Chester 1
Cisterna Di Latina 1
Cornate d'Adda 1
Totale 7.653
Nome #
Very late-onset friedreich ataxia with laryngeal dystonia 262
A complex craniovertebral junction malformation in a patient with late onset glycogenosis 2 159
A Novel Mutation in the Stalk Domain of KIF5A Causes a Slowly Progressive Atypical Motor Syndrome 149
COVID-19 impact on consecutive neurological patients admitted to the emergency department 138
Interpretation of the epigenetic signature of facioscapulohumeral muscular dystrophy in light of genotype-phenotype studies 126
A new mutation in the mitochondrial tRNAAla gene in a patient with ophthalmoplegia and dysphagia 125
Critical illness myopathy 123
Small nerve fiber pathology in critical illness 118
Idiopathic hypocomplementemic urticarial vasculitis-linked neuropathy 114
C9orf72 Intermediate Alleles in Patients with Amyotrophic Lateral Sclerosis, Systemic Lupus Erythematosus, and Rheumatoid Arthritis 112
A PCR-based protocol to accurately size C9orf72 intermediate-length alleles. 110
A novel mitochondrial tRNA(Ala) gene variant causes chronic progressive external ophthalmoplegia in a patient with Huntington disease. 108
Cortico-spinal tDCS in ALS: A randomized, double-blind, sham-controlled trial 108
A high-dose bortezomib neuropathy with sensory ataxia and myelin involvement. 105
Choreo-athetosis in LRRK2 R1441C mutation: expanding the clinical phenotype. 104
Novel mitochondrial tRNALeu(CUN) transition and D4Z4 partial deletion in a patient with a facioscapulohumeral phenotype 98
Neuropathology of mitochondrial diseases. 96
Exploring Olfactory Function and Its Relation with Behavioral and Cognitive Impairment in Amyotrophic Lateral Sclerosis Patients: A Cross-Sectional Study. 96
Mitochondrial DNA-related disorders. 95
MR Neurography in Diagnosing Nondiabetic Lumbosacral Radiculoplexus Neuropathy 93
Hemangioma of the semimembranosus muscle in a patient with late-onset glycogenosis II 93
The brain in late-onset glycogenosis II: a structural and functional MRI study. 91
Poor Outcome in a Mitochondrial Neurogastrointestinal Encephalomyopathy Patient with a NovelTYMPMutation: The Need for Early Diagnosis 90
Effects of short-to-long term enzyme replacement therapy (ERT) on skeletal muscle tissue in late onset Pompe disease (LOPD) 83
Coffee and amyotrophic lateral sclerosis: A possible preventive role 82
Editorial: Iron and Neurodegeneration 81
Nusinersen safety and effects on motor function in adult spinal muscular atrophy type 2 and 3 77
Clinical characteristics and outcomes of inpatients with neurologic disease and COVID-19 in Brescia, Lombardy, Italy 75
Magnetic resonance imaging of the peripheral nerve 71
Autosomal dominant psychiatric disorders and mitochondrial DNA multiple deletions: Report of a family 71
Advances in quantitative imaging of genetic and acquired myopathies: Clinical applications and perspectives 70
Muscle pain in mitochondrial diseases: a picture from the Italian network 69
Psychosocial impact of sport activity in neuromuscular disorders 68
Snake-Eye Myelopathy and Surgical Prognosis: Case Series and Systematic Literature Review 67
Autosomal recessive Bethlem myopathy: A clinical, genetic and functional study 67
Protein misfolding, amyotrophic lateral sclerosis and guanabenz: Protocol for a phase II RCT with futility design (ProMISe trial) 64
Impact of environmental factors and physical activity on disability and quality of life in CIDP 60
Eyelid ptosis from sympathetic nerve dysfunction mistaken as myopathy: A simple test to identify this condition 60
Analysis of C9Orf72 Expansions in Patients with Systemic Lupus Erythematosus and Rheumatoid Arthritis: Preliminary Data 59
Genome-wide association analyses identify new risk variants and the genetic architecture of amyotrophic lateral sclerosis 57
Strategies for treating mitochondrial disorders: An update 57
A novel CAPN1 mutation causes a pure hereditary spastic paraplegia in an Italian family 57
Vaccination recommendations for patients with neuromuscular disease 56
Genetic correlation between amyotrophic lateral sclerosis and schizophrenia 55
Could mitochondrial haplogroups play a role in sporadic amyotrophic lateral sclerosis? 54
ASAH1 variant causing a mild SMA phenotype with no myoclonic epilepsy: A clinical, biochemical and molecular study 53
Alterazioni delle fibre sensitive di piccolo calibro intra-epidermiche in pazienti con critical illness myopathy and neuropathy. Dati preliminari. 51
Frequency of diabetes and other comorbidities in chronic inflammatory demyelinating polyradiculoneuropathy and their impact on clinical presentation and response to therapy 51
Prevalence of asymptomatic vertebral fractures in late-onset pompe disease 50
Mitochondrial diseases: Advances and issues 49
Antioxidant agents have a different expression pattern in muscle fibers of patients with mitochondrial diseases 49
Becker muscular dystrophy due to an intronic splicing mutation inducing a dual dystrophin transcript 49
C9orf72 Intermediate Repeats Confer Genetic Risk for Severe COVID-19 Pneumonia Independently of Age 49
Plasma amino acids patterns and age of onset of amyotrophic lateral sclerosis 48
LOPED study: Looking for an early diagnosis in a late-onset Pompe disease high-risk population 48
RELEVANCE OF DIAGNOSTIC INVESTIGATIONS IN CHRONIC INFLAMMATORY DEMYELINATING POLIRADICULONEUROPATHY: DATA FROM THE ITALIAN CIDP DATABASE 47
Pitfalls in diagnosing mitochondrial neurogastrointestinal encephalomyopathy 47
A 5-year clinical follow-up study from the Italian National Registry for FSHD 46
Reversible upper limb muscle weakness with selective loss of thick filaments 46
Phenotypic Variability Among Patients With D4Z4 Reduced Allele Facioscapulohumeral Muscular Dystrophy 45
Progress in enzyme replacement therapy in glycogen storage disease type II 45
Late-onset glycogen storage disease type 2 45
Lipomatosis incidence and characteristics in an Italian cohort of mitochondrial patients 44
Genotype-phenotype correlation in Pompe disease, a step forward 44
Imaging of the muscle 43
Assessing the Role of Anti rh-GAA in Modulating Response to ERT in a Late-Onset Pompe Disease Cohort from the Italian GSDII Study Group 43
The role of mitochondria in neurodegenerative diseases 43
Human leukocyte antigens class II in CIDP spectrum neuropathies 42
Antimyoclonic effect of levetiracetam in MERRF syndrome 42
Dermatomyositis and retroperitoneal germ cell cancer 42
Subcutaneous immunoglobulin in CIDP and MMN: a different long-term clinical response? 42
Liver transplantation in mitochondrial neurogastrointestinal encephalomyopathy (MNGIE): clinical long-term follow-up and pathogenic implications 41
Observational clinical study in juvenile-adult glycogenosis type 2 patients undergoing enzyme replacement therapy for up to 4 years 41
Mitochondrial myopathy and complex III deficiency in a patient with a new stop-codon mutation (G339X) in the cytochrome b gene 40
The Genetic Landscape of Dystrophin Mutations in Italy: A Nationwide Study 40
T-cell anti-apoptotic mechanisms in inflammatory myopathies 39
A genome-wide association meta-analysis identifies a novel locus at 17q11.2 associated with sporadic amyotrophic lateral sclerosis 39
Decreased platelet cytochrome c oxidase activity is accompanied by increased blood lactate concentration during exercise in patients with Alzheimer disease 39
Muscle biopsy displaying "double trouble" pathology: Combined features of periodic paralysis and dermatomyositis 39
Progressive external ophthalmoplegia: A new family with tremor and peripheral neuropathy [1] 39
Infantile hepatocerebral syndromes associated with mutations in the mitochondrial DNA polymerase-γA 38
The role of brain MRI in mitochondrial neurogastrointestinal encephalomyopathy 38
Current options in the treatment of mitochondrial diseases 38
Clinical and Molecular Spectrum of Myotonia and Periodic Paralyses Associated With Mutations in SCN4A in a Large Cohort of Italian Patients 37
A mobile app for patients with Pompe disease and its possible clinical applications 37
Spinal muscular atrophy and mitochondrial DNA depletion. Response to Berber et al. (2003) Acta Neuropathol 105:245-251 37
Sarcoidosis and inclusion body myositis 36
Limb-girdle muscular dystrophy-associated protein diseases 36
A novel KCNA1 mutation in a patient with paroxysmal ataxia, myokymia, painful contractures and metabolic dysfunctions 35
Redefining phenotypes associated with mitochondrial DNA single deletion 35
Mutations in DNA2 link progressive myopathy to mitochondrial DNA instability 35
Mitochondrial neurogastrointestinal encephalomyopathy (MNGIE): Position paper on diagnosis, prognosis, and treatment by the MNGIE International Network 34
McArdle disease and sporadic inclusion body myositis 34
Course and management of allogeneic stem cell transplantation in patients with mitochondrial neurogastrointestinal encephalomyopathy 34
Allogeneic haematopoietic stem cell transplantation for mitochondrial neurogastrointestinal encephalomyopathy 33
Risk factors for chronic inflammatory demyelinating polyradiculoneuropathy (CIDP): antecedent events, lifestyle and dietary habits. Data from the Italian CIDP Database 33
Erythropoietin in amyotrophic lateral sclerosis: A multicentre, randomised, double blind, placebo controlled, phase III study 33
P301L Tau mutation and non-Alzheimer dementias in Italy 33
Transcription factors c-Jun/activator protein-1 and nuclear factor-kappa B in oxidative stress response in mitochondrial diseases 32
Expression of late myogenic differentiation markers in sarcoplasmic masses of patients with myotonic dystrophy 32
Totale 6.433
Categoria #
all - tutte 69.038
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 69.038


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/2019209 0 0 0 0 0 0 0 0 0 48 84 77
2019/2020808 99 39 34 91 56 84 89 82 70 94 27 43
2020/20214.337 20 50 188 359 1.790 262 134 384 271 485 104 290
2021/20221.225 27 293 25 39 11 81 137 91 85 57 115 264
2022/2023860 223 22 22 21 50 266 3 53 103 13 36 48
2023/20241.200 61 29 146 57 56 267 47 45 487 5 0 0
Totale 9.012